| Dr Arthur F Bergh, MD | |
|
3300 Gallows Rd, Falls Church, VA 22042-3307 | |
| (703) 776-3138 | |
| Not Available |
| Full Name | Dr Arthur F Bergh |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 31 Years |
| Location | 3300 Gallows Rd, Falls Church, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285677120 | NPI | - | NPPES |
| 1285677120 | Medicaid | VA | |
| 0063118000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | ME104878 (Florida) | Secondary |
| 207L00000X | Anesthesiology | 0101057502 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northstar Anesthesia Of Virginia, Llc | 6608268826 | 349 |
News Archive
A new study published in the prestigious journal JAMA Cardiology in May 2020 reports that there is no association between the use of ACEIs/ARBs and testing positive for COVID-19. This supports current medical advice to continue using these drugs as indicated irrespective of the ongoing pandemic but indicates the need for more research to rule out any additional risk of severe illness due to these agents.
Codexis, Inc. today announced an expansion of its relationship and the signing of its second agreement this year with Teva Pharmaceutical Industries Ltd., the world's largest generic drug manufacturer. The new agreement covers three undisclosed pharmaceutical products.
Now, a new study published in the preprint server bioRxiv in July 2020 reports on the antiviral activity of two drugs found in an antimalarial drug currently in phase II trials in South Korea, called Pyramax.
A new study by scientists at the Wayne State University School of Medicine demonstrates that communication between some of the brain's most important centers is altered in children with obsessive-compulsive disorder.
Tibotec Pharmaceuticals announced today the company will present the results of a Week-24 planned interim analysis of the phase 2 response-guided PILLAR study in treatment-naive patients with chronic genotype 1 hepatitis C virus (HCV) at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston, MA., USA. The data will be presented as part of a late-breaker oral presentation on Monday, November 1.
› Verified 1 days ago
| Entity Name | American Anesthesiology Of Virginia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417994872 PECOS PAC ID: 6800790023 Enrollment ID: O20031120000429 |
News Archive
A new study published in the prestigious journal JAMA Cardiology in May 2020 reports that there is no association between the use of ACEIs/ARBs and testing positive for COVID-19. This supports current medical advice to continue using these drugs as indicated irrespective of the ongoing pandemic but indicates the need for more research to rule out any additional risk of severe illness due to these agents.
Codexis, Inc. today announced an expansion of its relationship and the signing of its second agreement this year with Teva Pharmaceutical Industries Ltd., the world's largest generic drug manufacturer. The new agreement covers three undisclosed pharmaceutical products.
Now, a new study published in the preprint server bioRxiv in July 2020 reports on the antiviral activity of two drugs found in an antimalarial drug currently in phase II trials in South Korea, called Pyramax.
A new study by scientists at the Wayne State University School of Medicine demonstrates that communication between some of the brain's most important centers is altered in children with obsessive-compulsive disorder.
Tibotec Pharmaceuticals announced today the company will present the results of a Week-24 planned interim analysis of the phase 2 response-guided PILLAR study in treatment-naive patients with chronic genotype 1 hepatitis C virus (HCV) at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston, MA., USA. The data will be presented as part of a late-breaker oral presentation on Monday, November 1.
› Verified 1 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20040102000644 |
News Archive
A new study published in the prestigious journal JAMA Cardiology in May 2020 reports that there is no association between the use of ACEIs/ARBs and testing positive for COVID-19. This supports current medical advice to continue using these drugs as indicated irrespective of the ongoing pandemic but indicates the need for more research to rule out any additional risk of severe illness due to these agents.
Codexis, Inc. today announced an expansion of its relationship and the signing of its second agreement this year with Teva Pharmaceutical Industries Ltd., the world's largest generic drug manufacturer. The new agreement covers three undisclosed pharmaceutical products.
Now, a new study published in the preprint server bioRxiv in July 2020 reports on the antiviral activity of two drugs found in an antimalarial drug currently in phase II trials in South Korea, called Pyramax.
A new study by scientists at the Wayne State University School of Medicine demonstrates that communication between some of the brain's most important centers is altered in children with obsessive-compulsive disorder.
Tibotec Pharmaceuticals announced today the company will present the results of a Week-24 planned interim analysis of the phase 2 response-guided PILLAR study in treatment-naive patients with chronic genotype 1 hepatitis C virus (HCV) at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston, MA., USA. The data will be presented as part of a late-breaker oral presentation on Monday, November 1.
› Verified 1 days ago
| Entity Name | Northstar Anesthesia Of Virginia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194488791 PECOS PAC ID: 6608268826 Enrollment ID: O20220120002585 |
News Archive
A new study published in the prestigious journal JAMA Cardiology in May 2020 reports that there is no association between the use of ACEIs/ARBs and testing positive for COVID-19. This supports current medical advice to continue using these drugs as indicated irrespective of the ongoing pandemic but indicates the need for more research to rule out any additional risk of severe illness due to these agents.
Codexis, Inc. today announced an expansion of its relationship and the signing of its second agreement this year with Teva Pharmaceutical Industries Ltd., the world's largest generic drug manufacturer. The new agreement covers three undisclosed pharmaceutical products.
Now, a new study published in the preprint server bioRxiv in July 2020 reports on the antiviral activity of two drugs found in an antimalarial drug currently in phase II trials in South Korea, called Pyramax.
A new study by scientists at the Wayne State University School of Medicine demonstrates that communication between some of the brain's most important centers is altered in children with obsessive-compulsive disorder.
Tibotec Pharmaceuticals announced today the company will present the results of a Week-24 planned interim analysis of the phase 2 response-guided PILLAR study in treatment-naive patients with chronic genotype 1 hepatitis C virus (HCV) at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston, MA., USA. The data will be presented as part of a late-breaker oral presentation on Monday, November 1.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arthur F Bergh, MD 3100 Spring Forest Rd Ste 130, Raleigh, NC 27616-2880 Ph: (919) 882-0774 | Dr Arthur F Bergh, MD 3300 Gallows Rd, Falls Church, VA 22042-3307 Ph: (703) 776-3138 |
News Archive
A new study published in the prestigious journal JAMA Cardiology in May 2020 reports that there is no association between the use of ACEIs/ARBs and testing positive for COVID-19. This supports current medical advice to continue using these drugs as indicated irrespective of the ongoing pandemic but indicates the need for more research to rule out any additional risk of severe illness due to these agents.
Codexis, Inc. today announced an expansion of its relationship and the signing of its second agreement this year with Teva Pharmaceutical Industries Ltd., the world's largest generic drug manufacturer. The new agreement covers three undisclosed pharmaceutical products.
Now, a new study published in the preprint server bioRxiv in July 2020 reports on the antiviral activity of two drugs found in an antimalarial drug currently in phase II trials in South Korea, called Pyramax.
A new study by scientists at the Wayne State University School of Medicine demonstrates that communication between some of the brain's most important centers is altered in children with obsessive-compulsive disorder.
Tibotec Pharmaceuticals announced today the company will present the results of a Week-24 planned interim analysis of the phase 2 response-guided PILLAR study in treatment-naive patients with chronic genotype 1 hepatitis C virus (HCV) at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston, MA., USA. The data will be presented as part of a late-breaker oral presentation on Monday, November 1.
› Verified 1 days ago
Jeffrey Scheidlinger, Anesthesiology Medicare: Medicare Enrolled Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3138 | |
Jack A Stabile, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-689-3138 | |
Dr. Steven A Lussos, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3138 | |
Dr. Sabine E Duffy, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3138 Fax: 781-407-0998 | |
Dr. Roger A Denney, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3138 Fax: 540-982-2719 | |
Zhao Yang, M.D., PH.D Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3138 | |
Dr. Emma Alvaro Caligtan, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 201 North Washington Street, Falls Church, VA 22046 Phone: 703-237-4020 Fax: 703-536-1395 |